Asian healthtech deals surged 56.8% to US$4.97b in Q3

The highest deal worth US$146m was closed in China.

Asian healthtech investment deals skyrocketed 56.8% YoY from US$3.17b ($4.38b) to US$4.97b ($6.87b), healthtech connector Galen Growth Asia revealed.

The quarter saw 78 deals sealed, with seven of the biggest all coming from China. The highest deals were recorded by research startup LinkDoc and online health communities Medlinker which each received US$146m ($201.81b) worth of investments.

According to Galen Growth, US$2.25b ($3.11b) was raised by population health management firms. Medical diagnostics and online marketplace-related deals came in next with investments worth US$693m ($957.93b) and US$573m ($792.05b) YTD, respectively.

Other categories also clinched investment deals including the wellness segment with 19 deals YTD totalling US$305m ($421.60b), health management solutions with 28 deals YTD bagging US$287m ($396.72b), and research with 11 deals that reached US$226m ($312.40b).

Galen Growth Asia also noted that 50% of the Asia deals for online marketplaces where closed in India.